Invention Grant
US08877923B2 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
有权
取代的3-（5元不饱和杂环基-1,3-二氢 - 吲哚-2-酮及其衍生物作为激酶抑制剂
- Patent Title: Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
- Patent Title (中): 取代的3-（5元不饱和杂环基-1,3-二氢 - 吲哚-2-酮及其衍生物作为激酶抑制剂
-
Application No.: US13722113Application Date: 2012-12-20
-
Publication No.: US08877923B2Publication Date: 2014-11-04
- Inventor: Xialing Guo , Zhen Zhu , Thomas C. Malone
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Krishna Banerjee
- Main IPC: C07D405/04
- IPC: C07D405/04 ; C07D405/14 ; C07D409/14 ; C07F7/10 ; C07D417/14 ; C07D413/14
Abstract:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
Public/Granted literature
Information query
